Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer-Reference-Cited by-同舟云学术

Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer

Published:2008-05 Issue:2 Volume:109 Page:187-193
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ferrandina Gabriella,Ludovisi Manuela,Corrado Giacomo,Carone Vito,Petrillo Marco,Scambia Giovanni

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study;Eisenkop;Gynecol Oncol,2003

2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N Eng J Med,1996

3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study;Ozols;J Clin Oncol.,2003

4. Cancer statistics, 2006;Jemal;Ca Cancer J Clin,2006

5. Relapsed ovarian cancer: challenges and management strategies for a chronic disease;Armstrong;Oncologist,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial;Gynecologic Oncology;2021-08

2. Liposomal therapies in oncology: does one size fit all?;Cancer Chemotherapy and Pharmacology;2018-08-16

3. Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer;Hereditary Cancer in Clinical Practice;2016-01-23

4. CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review;Clinical and Translational Oncology;2015-11-06

5. Ovarian Cancer from Anatomy to Functional Imaging;Current Radiology Reports;2015-09-24